Table 2.

Survival data regarding the true outcome and the surrogate marker in IELSG19 trial

Double therapySingle therapyDifference between groups
Median PFS, y Not reached 8.35 — 
8y-PFS RMST, y 6.30 5.38 0.92 
Median TTCR, y 0.49 0.83 — 
TTCR24 RMST, y 1.03 0.71 0.32 
Double therapySingle therapyDifference between groups
Median PFS, y Not reached 8.35 — 
8y-PFS RMST, y 6.30 5.38 0.92 
Median TTCR, y 0.49 0.83 — 
TTCR24 RMST, y 1.03 0.71 0.32 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal